160 related articles for article (PubMed ID: 38376861)
1. Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer.
Shi X; Wang P; Li Y; Xu J; Yin T; Teng F
Thorac Cancer; 2024 Mar; 15(9):738-748. PubMed ID: 38376861
[TBL] [Abstract][Full Text] [Related]
2. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer.
Xu J; Wang P; Li Y; Shi X; Yin T; Yu J; Teng F
Front Immunol; 2024; 15():1373330. PubMed ID: 38686383
[TBL] [Abstract][Full Text] [Related]
5. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Qu J; Zhang T; Zhang X; Zhang W; Li Y; Gong Q; Yao L; Lui S
Clin Radiol; 2024 Apr; 79(4):e582-e591. PubMed ID: 38310058
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer.
Wu J; Zhou Y; Xu C; Yang C; Liu B; Zhao L; Song J; Wang W; Yang Y; Liu N
BMC Cancer; 2024 Feb; 24(1):170. PubMed ID: 38310283
[TBL] [Abstract][Full Text] [Related]
7. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
[TBL] [Abstract][Full Text] [Related]
8. Precise prediction of the sensitivity of platinum chemotherapy in SCLC: Establishing and verifying the feasibility of a CT-based radiomics nomogram.
Su Y; Lu C; Zheng S; Zou H; Shen L; Yu J; Weng Q; Wang Z; Chen M; Zhang R; Ji J; Wang M
Front Oncol; 2023; 13():1006172. PubMed ID: 37007144
[TBL] [Abstract][Full Text] [Related]
9. A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study.
Zheng X; Liu K; Li C; Zhu C; Gao Y; Li J; Wu X
Radiol Med; 2023 Nov; 128(11):1386-1397. PubMed ID: 37597124
[TBL] [Abstract][Full Text] [Related]
10. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
Sun F; Chen Y; Chen X; Sun X; Xing L
Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients.
Li C; Yin J
Front Oncol; 2021; 11():671354. PubMed ID: 34041033
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.
Shi L; Wang L; Wu C; Wei Y; Zhang Y; Chen J
Front Oncol; 2022; 12():927077. PubMed ID: 35875061
[TBL] [Abstract][Full Text] [Related]
13. Feasibility analysis of magnetic resonance imaging-based radiomics features for preoperative prediction of nuclear grading of ductal carcinoma in situ.
Zhao MR; Ma WJ; Song XC; Li ZJ; Shao ZZ; Lu H; Zhao R; Guo YJ; Ye ZX; Liu PF
Gland Surg; 2023 Sep; 12(9):1209-1223. PubMed ID: 37842532
[TBL] [Abstract][Full Text] [Related]
14. MRI radiomics-based nomogram for individualised prediction of synchronous distant metastasis in patients with clear cell renal cell carcinoma.
Bai X; Huang Q; Zuo P; Zhang X; Yuan J; Zhang X; Wang M; Xu W; Ye H; Zhao J; Sun H; Shao B; Wang H
Eur Radiol; 2021 Feb; 31(2):1029-1042. PubMed ID: 32856163
[TBL] [Abstract][Full Text] [Related]
15. Preoperative CT Radiomics Nomogram for Predicting Microvascular Invasion in Stage I Non-Small Cell Lung Cancer.
Deng L; Tang HZ; Luo YW; Feng F; Wu JY; Li Q; Qiang JW
Acad Radiol; 2024 Jan; 31(1):46-57. PubMed ID: 37331866
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
17. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
18. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
Jiang Z; Wang B; Han X; Zhao P; Gao M; Zhang Y; Wei P; Lan C; Liu Y; Li D
Eur Radiol; 2022 Apr; 32(4):2266-2276. PubMed ID: 34978579
[TBL] [Abstract][Full Text] [Related]
19. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma.
Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G
Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545
[TBL] [Abstract][Full Text] [Related]
20. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
